Representative before the EPO

Technology company logo thumb
no operation time available
Technology Company

Ulrike Hildegard Heiroth has worked on the following 13 EPO patent applications which have been published in the last five years:

EP12846324

ANTIBODY FORMULATIONS

IPC classification:
C07K 16/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Ulrike Hildegard Heiroth, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP13768451

METHODS OF PROGNOSING, DIAGNOSING AND TREATING IDIOPATHIC PULMONARY FIBROSIS

IPC classification:
A61K 38/00, A61K 39/395, C07K 16/00, C12Q 1/68, G01N 33/53
Applicant:
F. Hoffmann-La Roche AG
Agent:
Ulrike Hildegard Heiroth, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP13729940

SUBSTITUTED PYRAZOLE COMPOUNDS AS LPAR ANTAGONISTS

IPC classification:
A61K 31/192, A61P 19/04, C07D 231/40
Applicant:
F. Hoffmann-La Roche AG
Agent:
Ulrike Hildegard Heiroth, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP13729332

N-ARYLTRIAZOLE COMPOUNDS AS LPAR ANTAGONISTS

IPC classification:
A61K 31/4192, A61K 31/4196, A61P 29/00, A61P 37/00, C07D 249/06, C07D 249/14
Applicant:
F. Hoffmann-La Roche AG
Agent:
Ulrike Hildegard Heiroth, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP13729330

N-ALKYLTRIAZOLE COMPOUNDS AS LPAR ANTAGONISTS

IPC classification:
A61K 31/4192, A61P 29/00, A61P 37/00, C07D 249/06
Applicant:
F. Hoffmann-La Roche AG
Agent:
Ulrike Hildegard Heiroth, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP13756155

LPAR - SUBSTITUTED CYANOPYRAZOLE COMPOUNDS

IPC classification:
A61K 31/415, A61P 29/00, C07D 231/38
Applicant:
F. Hoffmann-La Roche AG
Agent:
Ulrike Hildegard Heiroth, F. Hoffmann-La Roche AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13844154

METHODS FOR DIAGNOSING AND TREATING INFLAMMATORY BOWEL DISEASE

IPC classification:
A61P 37/02, C12Q 1/00, C12Q 1/68
Applicant:
F. Hoffmann-La Roche AG
Agent:
Ulrike Hildegard Heiroth, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP14774938

USE OF BIOMARKERS FOR ASSESSING TREATMENT OF GASTROINTESTINAL INFLAMMATORY DISORDERS WITH BETA7 INTEGRIN ANTAGONISTS

IPC classification:
G01N 33/00, G01N 33/53
Applicant:
F. Hoffmann-La Roche AG
Agent:
Ulrike Hildegard Heiroth, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP14844960

METHODS AND COMPOSITIONS COMPRISING PURIFIED RECOMBINANT POLYPEPTIDES

IPC classification:
A61K 39/395
Applicant:
F. Hoffmann-La Roche AG
Agent:
Ulrike Hildegard Heiroth, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP14789717

NSP4 INHIBITORS AND METHODS OF USE

IPC classification:
C07K 16/24
Applicant:
F. Hoffmann-La Roche AG
Agent:
Ulrike Hildegard Heiroth, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP14856518

METHODS OF DIAGNOSING AND TREATING EOSINOPHILIC DISORDERS

IPC classification:
C12Q 1/68
Applicant:
F. Hoffmann-La Roche AG
Agent:
Ulrike Hildegard Heiroth, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP16169916

ANTI-IL13 ANTIBODY FORMULATIONS

IPC classification:
A61K 39/395, A61K 47/18, A61K 47/26, A61M 5/24, C07K 16/24
Applicant:
F. Hoffmann-La Roche AG
Agent:
Ulrike Hildegard Heiroth, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP15768557

METHODS FOR DIAGNOSING AND TREATING INFLAMMATORY BOWEL DISEASE

IPC classification:
A61K 38/00, A61K 39/00, C07K 16/00, C12P 21/08, C12Q 1/68
Applicant:
F. Hoffmann-La Roche AG
Agent:
Ulrike Hildegard Heiroth, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature